Panlong Pharmaceutical

002864
22.120.18% ( +0.04 )
Delay Midday Break: Nov 16, 11:30:00

Financials

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: Panlong Pharmaceutical(002864) the Revenue is 195.39 M (-26.94%);the EBIT is 24.4 M (-33.25%);the EPS is 0.101 (-54.11%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.20B26.94%
----
----
EBIT
0.02B33.25%
----
----
EPS
0.10154.11%
----
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateApr 23, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: CNY
Quarterly

EBIT

ActualEstimateUnit: CNY
Quarterly

Net income

ActualEstimateUnit: CNY
Quarterly

EPS

ActualEstimateUnit: CNY
Quarterly